all report title image
  • Published On : Oct 2022
  • Code : CMI5269
  • Industry : Medical Devices
  • Pages : 302
  • Formats :

A picture archiving and communication system (PACS) is a therapeutic imaging technology that provides storage and useful access to images in numerous manner. Ophthalmology PACS is used to transfer or communicate electrical images and reports at different places. This removes the need to physically file, recover, or transport film jackets, the files used to store and protect X-ray film.

  • With ophthalmology PACS, medical images of patients with eye diseases are taken and studied for medical examination, findings, and treatment. The evidence collected can be used to classify any structural and physical abnormalities.
  • The increasing prevalence of eye diseases globally is expected to increase the demand  ophthalmology PACS worldwide.
  • Ophthalmology PACS is used to store medical documents and pictures securely in off-site servers and be securely opened from anywhere in the world using PACS software, portable devices, etc.

Global Ophthalmology PACS Market - Impact of the Coronavirus (COVID-19) Pandemic

The COVID-19 pandemic is expected to hamper the growth of the global ophthalmology PACS market owing to a decline in patient’s clinical visits. For instance, according to the data published on December 2, 2021 by the National Institute of Heath, U.S., the COVID-19 pandemic has adversely affected admission to eye care clinics due to travel limitations, unemployment-related financial challenges, fear of infection, etc. There was an extreme decline in clinic visits and procedures which is expected to hamper the growth of the global ophthalmology PACS market.

Moreover, a decline in eye disease treatment during COVID-19 is expected to hamper the global ophthalmology PACS market growth. For instance, according to the data published in July 2020 in the Indian Journal of Ophthalmology, the COVID-19 pandemic has a huge negative impact on the working of eye-care hospitals. The lockdown has put a burden on patients, clinicians, staff, and the hospital management. COVID-19 pandemic and government-imposed restrictions have brought financial, logistic, and psychological challenges. This made reduction of visit of patient to eye clinics and hospitals this resulted into decline in eye treatment which is expected to hamper the growth of global ophthalmology PACS market.

The global ophthalmology PACS market is estimated to be valued at US$ 201.18 Mn in 2022 and is expected to exhibit a CAGR of 5.9% over the forecast period (2022-2030).

Figure 1: Global Ophthalmology PACS Market Share, (%), Analysis, By Type, 2022

Ophthalmology PACS  | Coherent Market Insights

Market players are involved in signing agreements with other key players, in order to expand their services. This is expected to drive the growth of the global ophthalmology PACS market over the forecast period.

Market players are involved in signing agreements and this is expected to drive growth of the global ophthalmology PACS market over the forecast period. For instance, in July 2018, IBM, a technology company, announced an agreement with Anthem Inc., a healthcare company, for the expansion of service agreement to drive the digital transformation and deliver an improved digital experience to healthcare consumers. According to the agreement, IBM had provided Anthem with initiative services for its mainframe, data center server, and storage infrastructure management. The growth of digital transformation in the healthcare sector is expected to drive the global ophthalmology PACS market growth. 

CMI table icon

Ophthalmology PACS Market Report Coverage

Report Coverage Details
Base Year: 2021 Market Size in 2022: US$ 201.18 Mn
Historical Data for: 2018 to 2020 Forecast Period: 2022 to 2030
Forecast Period 2022 to 2030 CAGR: 5.9% 2030 Value Projection: US$ 319.17 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Type: Integrated PACS, Standalone PACS
  • By Delivery Model: Cloud-Based Model, On-Premise Model
  • By End User: Hospitals, Speciality Clinics
Companies covered:

Topcon Corporation, Agfa-Gevaert N.V., Sonomed Escalon, Carl Zeiss Meditec AG, EyePACS, VersaSuite, Heidelberg Engineering GmbH, ScImage, Inc., IBM Corporation, and Visbion Limited

Growth Drivers:
  • Increasing agreement between key players for the expansion of services
  • Increasing product approvals by the regulatory authorities
  • Increasing prevalence of eye disease
Restraints & Challenges:
  • Increasing product recalls by manufacturers

Key players are engaged in receiving approvals for their products from regulatory authorities, and this is expected to drive the growth of the global ophthalmology PACS market over the forecast period.

Product approvals by regulatory bodies is expected to drive the growth of the global ophthalmology PACS market over the forecast period. For instance, on April 20, 2022, Carl Zeiss Sports Optics, a technology enterprise operating in the fields of optics and optoelectronics, announced that it received approval for QUATERA 700 from the U.S. Food and Drug Administrator. QUATERA 700 was made to develop a surgeon’s workflow effectiveness from the clinic to the operating room, allowing one digitally integrated surgical workflow. It works as a single sterile operating room dashboard integrating patient data from other systems and the microscope view. 

Global Ophthalmology PACS Market – Restraints

An increasing number of product recalls is expected to hamper the growth of the global ophthalmology PACS market over the forecast period. For instance, on March 13, 2017, Merge Healthcare, Inc., a provider of digital solution for healthcare, had recalled Class 2 Device, Merge Eye Care Systems, which consist of Merge Eye Station, Merge Eye Care PACS, and Merge Eye Station Import Utility. The system was recalled as it completely stopped allowing the downloading or acquisition of new images due to incompatible software application versions. This is expected to hamper the growth of the global ophthalmology PACS market. 

Global Ophthalmology PACS Market – Regional Analysis

On the basis of region, the global ophthalmology PACS market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Among regions, the North America ophthalmology PACS market is expected to hold a dominant position during the forecast period, owing to increasing inorganic activities such as acquisition by key players. For instance, in August 2017, Carl Zeiss Meditec Inc., a U.S.-based medical technology manufacturer, acquired Veracity Innovations, LLC, a medical software company which provides cloud-based platforms to its customers for increased medical performance. The acquisition was aimed at increasing the Carl Zeiss Meditec’s eye care-based digital solution collection. These software had supported ophthalmologists in bringing modified technology-empowered care to their patients.

Furthermore, India is estimated to witness significant growth in the global ophthalmology PACS market, owing to the increasing prevalence of eye disease in the country. For instance, according to the data published in February 2018 by the National Institute of Health, U.S., the prevalence of dry eye disease in India was up to 54.3%, as compared with the global prevalence of dry eye disease. Increase prevalence of dry eye disease is expected to drive the ophthalmology PACS market growth.

Figure 2: Global Ophthalmology PACS Market (US$ Mn), by Region, 2022

Ophthalmology PACS  | Coherent Market Insights

Global Ophthalmology PACS Market – Competitive Landscape

Major players operating in the global ophthalmology PACS market include Topcon Corporation, Agfa-Gevaert N.V., Sonomed Escalon, Carl Zeiss Meditec AG, EyePACS, VersaSuite, Heidelberg Engineering GmbH, ScImage, Inc., IBM Corporation, and Visbion Limited. 

Picture Archiving and Communication System (PACS) is a medical imaging technology used in healthcare organizations. A PACS has diverse types of data and databases, which are usually stored in different formats. They contain demographic, images, and Digital Imaging and Communications in Medicine (DICOM) data. Image data may be treated as objects while patient data may be stored as script. Having access to a patient's most recent clinical pictures, medical reports, and history digitally helps speed up, enhance care and improve therapy. Digital access can advance patient safety and save healthcare facility and the patient’s time and money.

PACS has four machineries which include hardware imaging machines, a secure network for the transmission and exchange of patient pictures, mobile device for viewing, processing, and interpreting images, and electronic records for storage and retrieving images and related reports.

Market Dynamics

Market players are involved in advancing technologies for ophthalmic care, which is further expected to drive the growth of the global ophthalmology PACS market over the forecast period. For instance, on April 6, 2022, Carl Zeiss Meditec AG, a medical technology company, displayed medical viewpoints from global experts whose experiences support the importance of integrating devices, data, and software applications. New integrated ophthalmic workflows allow to create a digital environment where connectivity, automation, artificial intelligence, and safe management of data are redesigned for patient care.

Updated guidelines by regulatory bodies for securing Picture Archiving and Communication System is also expected to drive the growth of the global ophthalmology PACS market over the forecast period. For instance, in September 2019, the National Cybersecurity Center of Excellence (NCCoE) had updated guidelines for securing PACS such as improve flexibility in the network infrastructure with controlling a capability of a person trying to harm the computers device or systems of the healthcare delivery organization and controlling the unauthorized movement of files within the healthcare delivery organization by official system operators as well as it analyzes the actions and detect malware throughout the ecosystem and also NCCoE protects sensitive data. Increasing security for protecting PACS data is expected to boost the global ophthalmology PACS market growth.

Key features of the study:

  • This report provides an in-depth analysis of the global ophthalmology PACS market, market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global ophthalmology PACS market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Topcon Corporation, Agfa-Gevaert N.V., Sonomed Escalon, Carl Zeiss Meditec AG, EyePACS, VersaSuite, Heidelberg Engineering GmbH, ScImage, Inc., IBM Corporation, and Visbion Limited
  • Insights from this report would allow marketers and management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global ophthalmology PACS market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global ophthalmology PACS market

Detailed Segmentation:

  • Global Ophthalmology PACS Market, By Type:
    • Integrated PACS
    • Standalone PACS
  • Global Ophthalmology PACS Market, By Delivery Model:
    • Cloud-Based Model
    • On-Premise Model
  • Global Ophthalmology PACS Market, By End User:
    • Hospitals
    • Speciality Clinics
  • Global Ophthalmology PACS Market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Topcon Corporation *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Agfa-Gevaert N.V.
    • Sonomed Escalon
    • Carl Zeiss Meditec AG
    • EyePACS
    • VersaSuite
    • Heidelberg Engineering GmbH
    • ScImage, Inc.
    • IBM Corporation
    • Visbion Limited

“*” marked represents similar segmentation in other categories in the respective section.

Frequently Asked Questions

Global ophthalmology PACS market is expected to exhibit a CAGR of 5.9%, during the forecast period (2022-2030).
The market is estimated to be valued at US$ 201.18 Mn in 2022.
Topcon Corporation, Agfa-Gevaert N.V., Sonomed Escalon, Carl Zeiss Meditec AG, EyePACS, VersaSuite, Heidelberg Engineering GmbH, ScImage, Inc., IBM Corporation, and Visbion Limited are some of the prominent players operating in the market.
The market is expected to be valued at US$ 319.17 Mn in 2030.
North America is the prominent region in the market.
Integrated PACS is the prominent type segment in the market.

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo